Pharma Journalist -

Lyric Pharmaceuticals which is a biopharmaceutical company asserted the completion of enlisting for PROMOTE Study which is an international multi-center, randomized, controlled Phase 2…
Read More...

Global pharmaceutical company, Glenmark affirmed poster presentations of data from clinical studies of Ryaltris which is an investigational fixed-dose combination nasal spray for…
Read More...

MicuRx Pharmaceuticals asserted that the global partnership Combating Antibiotic Resistant Bacteria Accelerator has dedicated up to $5.2 million of non-dilutive financing for IND…
Read More...

SMi's 5th Annual Pre-Filled Syringes East Coast Conference and Exhibition (April 11 – 12, Boston, USA) will gather together 100+ CEOs and decision makers in the field of PFS, so entire…
Read More...

Aimmune Therapeutics which is a bio pharmaceutical company curating treatments for fatal food allergies, announced that the results of its pivotal Phase 3 PALISADE trial of AR101 for…
Read More...

London and New York based gene therapy company, MeiraGTx declared that the European Medicines Agency has extended Priority Medicines (PRIME) designation to MeiraGTx’s gene therapy…
Read More...

Unum Therapeutics  which is a clinical-stage bio pharmaceutical company focused on the development of novel immunotherapy products designed to utilize the power of  patient's immune…
Read More...

SMi’s 2nd Annual Pharmaceutical Microbiology West Coast Conference will be taking place in San Diego, USA on the 7th - 8th June 2018.The conference will be focusing on the various…
Read More...

Cardiovascular Systems, Inc which is a medical device company curating and developing breakthrough interventional treatment systems for patients with peripheral and coronary artery…
Read More...

Biogen and Abbvie asserted voluntary worldwide withdrawal of ZINBRYTA for relapsing multiple sclerosis. Taking into account the limited number of patients who are being treated,…
Read More...